Average Co-Inventor Count = 12.56
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Fremont Inc. (14 from 78 patents)
2. Amgen Inc. (2 from 1,975 patents)
3. Celldex Therapeutics Limited (1 from 45 patents)
16 patents:
1. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
2. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
3. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
4. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
5. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
6. 9073998 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
7. 9062113 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
8. 8846873 - Antibodies directed to GPNMB and uses thereof
9. 8101178 - Antibodies directed to tumor necrosis factor and uses thereof
10. 7994302 - Fully human monoclonal antibodies to IL-13
11. 7964193 - Antibodies against interleukin-1 β
12. 7736644 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
13. 7628986 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
14. 7585500 - Fully human monoclonal antibodies to IL-13
15. 7566772 - Antibodies against interleukin-1β